Global Non-invasive Blood Glucose Detector Market Insights, Forecast to 2030

Global Non-invasive Blood Glucose Detector Market Insights, Forecast to 2030

According to research surveys and interviews by QYResearch, there are very few non-invasive blood glucose monitors currently on the market that meet medical non-invasive standards and blood sugar accuracy, and are CE and FDA certified. Most companies are in the research and development stage, so the data in the report includes minimally invasive products and non-invasive products. Among the minimally invasive products are CGM devices provided by Abbott and Dexcom that do not require finger pricking. Non-invasive products are provided by Cnoga Medical and Ghalife. And Cnoga Medical’s product is the non-invasive module part of a hybrid blood glucose meter. This report also provides a detailed introduction to the research companies in this industry and the products they are developing.

The global Non-invasive Blood Glucose Detector market is projected to grow from US$ 4,745.81 million in 2024 to US$ 18,058.53 million by 2030, at a Compound Annual Growth Rate (CAGR) of 24.95% during the forecast period.

The United States & Canada market for Non-invasive Blood Glucose Detector is estimated to increase from $ 1,460.11 million in 2024 to reach $ 5,931.12 million by 2030, at a CAGR of 26.32% during the forecast period of 2025 through 2030.

The China market for Non-invasive Blood Glucose Detector is estimated to increase from $ 382.83 million in 2024 to reach $ 1,704.58 million by 2030, at a CAGR of 28.26% during the forecast period of 2024 through 2030.

The Europe market for Non-invasive Blood Glucose Detector is estimated to increase from $ 1,852.62 million in 2024 to reach $ 6,388.60 million by 2030, at a CAGR of 22.91% during the forecast period of 2025 through 2030.

The global key manufacturers of Non-invasive Blood Glucose Detector include Abbott, Dexcom, Cnoga Medical, Ghalife. In 2023, the global top two players had a share approximately 68.94% in terms of revenue.

Report Includes

This report presents an overview of global market for Non-invasive Blood Glucose Detector, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Non-invasive Blood Glucose Detector, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Non-invasive Blood Glucose Detector, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-invasive Blood Glucose Detector sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Non-invasive Blood Glucose Detector market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Non-invasive Blood Glucose Detector sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Abbott, Dexcom, Cnoga Medical , Ghalife.

Market Segmentation

By Company

Abbott

Dexcom

Cnoga Medical

Ghalife (GHA)

Glucowise (Meta Materials Inc.)

GlucoTrack

Know Labs

Light Touch Technology

DiaMonTech

Taiwan Biophotonic

Afon Technology

Hagar

RSP systems

PKVitality

LifePlus

Segment by Type

Wearable

Non-Wearable

Segment by Application

Hospitals and Clinics

At-home Use

Others

Segment by Region

US & Canada

U.S.

Canada

APAC (excluding China)

Japan

South Korea

Southeast Asia

India

Australia

Europe

Germany

France

U.K.

Italy

Russia

China

Middle East, Africa, Latin America

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Non-invasive Blood Glucose Detector in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Non-invasive Blood Glucose Detector manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: MEA and Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-invasive Blood Glucose Detector sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.